Borys Chabursky, Director at Purepoint Uranium, holds 457.50K shares in Acerus Pharmaceuticals (Ticker: ASPCF), holds 5.00M shares in Minera Alamos (Ticker: TSE:MAI), holds 666.67K shares in Purepoint Uranium (Ticker: TSE:PTU). Most recently, Borys Chabursky Bought ― shares of Acerus Pharmaceuticals on Nov 17, 2020 for an estimated value of 12.00K.
Borys Chabursky latest transaction was an Informative Buy of $12.00K.
What was Borys Chabursky's most profitable transaction?
Borys Chabursky’s most profitable transaction was an Informative Buy of TSE:MAI stock on August 17, 2015. The return on the trade was 125.40%.
What is Borys Chabursky's role in Purepoint Uranium?
Borys Chabursky's role in Purepoint Uranium is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.